Wealthcare Advisory Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-947
Closed -$94K 1484
2019
Q3
$94K Buy
947
+321
+51% +$30.5K 0.01% 410
2019
Q2
$58K Buy
626
+20
+3% +$1.9K 0.01% 475
2019
Q1
$57K Sell
606
-72
-11% -$6.3K 0.01% 436
2018
Q4
$43K Sell
678
-124
-15% -$9.15K 0.01% 464
2018
Q3
$72K Sell
802
-306
-28% -$27K 0.01% 398
2018
Q2
$88K Sell
1,108
-930
-46% -$77.2K 0.02% 356
2018
Q1
$182K Sell
2,038
-611
-23% -$58.7K 0.04% 205
2017
Q4
$276K Buy
2,649
+214
+9% +$24.1K 0.07% 145
2017
Q3
$355K Buy
+2,435
New +$332K 0.11% 106

Other funds holding CELG

Wealthcare Advisory Partners's CELG Position: Q4 2019 in Review

Wealthcare Advisory Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 947 shares — an estimated $94K sold.

Wealthcare Advisory Partners first reported a position in CELG in Q3 2017 and held it in 9 quarters. The position peaked at $355K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Wealthcare Advisory Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 947 Celgene Corp shares in Q4 2019, an estimated $94K.
  • Wealthcare Advisory Partners first reported a position in Celgene Corp in Q3 2017 and held it in 9 quarters.
  • Wealthcare Advisory Partners's Celgene Corp position peaked at $355K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Wealthcare Advisory Partners's 13F filing for Q4 2019, filed 29 Jan 2020.